Search for: "SEC v. Capital Gains Research Bureau, Inc."
Results 1 - 14
of 14
Sorted by Relevance
|
Sort by Date
20 Sep 2017, 6:51 am
Capital Gains Research Bureau, Inc. 375 U.S. 18 (December 9, 1963) (.pdf) SEC v. [read post]
22 Aug 2019, 6:56 am
Capital Gains Research Bureau, Inc., 375 U.S. 180 (1963), the advisers owe to their clients a duty of good faith and full and fair disclosure of all material facts and a duty to avoid misleading them.According to the complaint, FDC (wholly-owned by Mr. [read post]
8 Mar 2012, 5:00 am
Capital Gains Research Bureau, Inc. 375 U.S. 18 (December 9, 1963) (.pdf) SEC v. [read post]
18 Dec 2013, 3:05 pm
Partners, Inc., 708 F.3d 470, 503 (3d Cir. 2013) (citing SEC v. [read post]
3 Nov 2019, 6:18 am
Capital Gains Research Bureau, Inc.: Nor is it necessary in a suit against a fiduciary, which Congress recognized the investment adviser to be, to establish all the elements required in a suit against a party to an arm’s-length transaction. [read post]
24 Apr 2018, 5:54 am
Capital Gains Research Bureau, Inc. [read post]
24 Jan 2011, 7:15 am
Capital Gains Research Bureau, Inc., 375 U.S. 180 (1963). which held that an advisor’s “scalping,” or purchasing shares before recommending them and then selling on the rise in market price, “operates as a fraud or deceit upon any client. [read post]
30 Nov 2011, 5:21 am
Capital Gains Research Bureau, Inc., 375 U.S. 180, 191, 194 (1963). [read post]
9 Oct 2007, 9:17 am
Capital Gains Research Bureau, 375 U.S. 180 (1963). [read post]
2 Oct 2019, 10:21 am
Clayton County, GA (No. 17-1618) and Altitude Express, Inc. v. [read post]
13 Jul 2021, 5:30 am
Congress does actually attempt to legislate for the safety and well-being of U.S. citizens in their efforts to ensure we have safe food and pharmaceuticals, and trustworthy capital markets, among many ot [read post]
4 Oct 2011, 8:48 pm
In Stolt-Nielsen S.A. v. [read post]
5 Jan 2020, 2:52 pm
Supreme Court’s March 2018 entry of its opinion in Cyan, Inc. v. [read post]
5 Jan 2020, 2:52 pm
Supreme Court’s March 2018 entry of its opinion in Cyan, Inc. v. [read post]
